Henry James International Management Inc. Sells 443 Shares of Amdocs Limited (NASDAQ:DOX)

Henry James International Management Inc. trimmed its stake in shares of Amdocs Limited (NASDAQ:DOX) by 14.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 2,694 shares of the technology company’s stock after selling 443 shares during the quarter. Henry James International Management Inc.’s holdings in Amdocs were worth $237,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC bought a new stake in Amdocs during the 4th quarter worth approximately $25,000. Operose Advisors LLC boosted its holdings in Amdocs by 148.0% in the third quarter. Operose Advisors LLC now owns 310 shares of the technology company’s stock valued at $26,000 after acquiring an additional 185 shares during the last quarter. Oakworth Capital Inc. acquired a new stake in Amdocs during the 4th quarter valued at approximately $26,000. VisionPoint Advisory Group LLC lifted its position in shares of Amdocs by 77.7% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 503 shares of the technology company’s stock worth $42,000 after purchasing an additional 220 shares during the period. Finally, Allworth Financial LP increased its position in shares of Amdocs by 16,840.0% during the third quarter. Allworth Financial LP now owns 847 shares of the technology company’s stock worth $72,000 after buying an additional 842 shares during the period. Institutional investors own 92.02% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on DOX. Barclays lifted their price objective on shares of Amdocs from $105.00 to $115.00 and gave the company an “overweight” rating in a research note on Thursday, February 8th. StockNews.com downgraded shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, March 15th. Finally, Citigroup raised their price target on shares of Amdocs from $96.00 to $104.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, Amdocs presently has a consensus rating of “Buy” and a consensus price target of $108.60.

Amdocs Stock Performance

NASDAQ:DOX traded up $0.26 during trading on Friday, reaching $83.90. The company’s stock had a trading volume of 660,338 shares, compared to its average volume of 592,389. Amdocs Limited has a 12 month low of $78.38 and a 12 month high of $99.75. The firm has a market cap of $9.86 billion, a price-to-earnings ratio of 17.97, a price-to-earnings-growth ratio of 1.36 and a beta of 0.70. The firm has a 50 day moving average of $88.95 and a 200-day moving average of $87.39. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.29 and a current ratio of 1.29.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings data on Tuesday, February 6th. The technology company reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.16. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. The business had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.24 billion. During the same quarter last year, the company posted $1.33 earnings per share. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. Research analysts expect that Amdocs Limited will post 5.87 EPS for the current fiscal year.

Amdocs Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 26th. Investors of record on Friday, March 29th were issued a $0.479 dividend. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $1.92 annualized dividend and a yield of 2.28%. This is a positive change from Amdocs’s previous quarterly dividend of $0.44. Amdocs’s dividend payout ratio (DPR) is 41.11%.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.